Therefore, the aim of our study was to evaluate whether dapagliflozin, an SGLT2 inhibitor, could improve cognitive impairment caused by long‐term HFD consumption in female mice and to explore the underlying mechanisms involved. The gene discussed is SLC5A2; the disease is Cognitive impairment.